In a free society, individuals should be free to care for their physical well-being as they see fit, which includes the freedom to choose the medical treatments they think best. Such liberty does not open the door for fraud or abuse any more than does a free market in other products. In fact, informed consent by patients will become more sophisticated as the market for information about medical treatments becomes more free and open.

More on FDA and Drug Regulation

Commentary

Arizona’s Opioid Policy Is Still Not Working

By Jeffrey A. Singer. In Defense of Liberty. December 19, 2018.

The Drug Prohibition Is to Blame for Opioid Crisis

By Jeffrey A. Singer. Daily Caller. December 4, 2018.

Pharmaceutical Industry Pays Price for Alliance With Obama Administration

By Doug Bandow. American Spectator. October 30, 2018.

Cato Studies

Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths

By Jeffrey A. Singer. Policy Analysis No. 858. December 13, 2018.

Promoting Wellness or Waste? Evidence from Antidepressant Advertising

By Bradley Shapiro. Research Briefs in Economic Policy No. 119. June 27, 2018.

Abuse-Deterrent Opioids and the Law of Unintended Consequences

By Jeffrey A. Singer. Policy Analysis No. 832. February 6, 2018.

Articles

Drug Rebates Do Not Increase Costs to Consumers

Ike Brannon. SSRN Working Paper. May 29, 2018.

A Deadly Grip: Wisconsin’s Opioid Scourge: Its Origins and Possible Solutions

Ike Brannon and Devorah Goldman. Wisconsin Interest. Spring 2017.

Public Filings

Merck v. Albrecht

By Erik S. Jaffe, Gene C. Schaerr, Ilya Shapiro, & Trevor Burrus. Legal Briefs. November 21, 2018.

Unintended Consequences: Medicaid and the Opioid Epidemic

By David A. Hyman. Testimony. January 17, 2018.

Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. South Carolina

By Pratik A. Shah, Matthew A. Scarola, Hyland Hunt, Ilya Shapiro, & Randal John Meyer. Legal Briefs. December 9, 2015.

Cato Reviews & Journals

Why Can’t Food Be Genetically Engineered and Organic?

Henry I. Miller and John J. Cohrssen. Regulation. Fall 2018.

USDA Is Supposed to Regulate Animal Health, Not Animal Happiness

Henry I. Miller and Jeff Stier. Regulation. Summer 2018.

Prescription for Lower Drug Prices: More OTC Transitions

Sam Peltzman. Regulation. Spring 2018.

Events

Overturning the FDA’s Gag Rule

Featuring Howard Root, Christina Sandefur, Jessica Flanigan, & Michael F. Cannon. February 7, 2018. Policy Forum.

Cato Institute Policy Perspectives 2018

Featuring Harrison Moar, Jeffrey A. Singer, Ryan Bourne, & Clint Bolick. January 18, 2018. City Seminar.

A “Modern Plague”? How the Federal Government Should Address the Opioid Crisis

Featuring Jeffrey A. Singer, Adam Bates, and Peter Russo. June 28, 2017. Capitol Hill Briefing.